Healthcare Services

Prothrombin Complex Concentrate Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers

June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Prothrombin Complex Concentrate Market During The Forecast Period?

The prothrombin complex concentrate market has demonstrated significant expansion in recent years. Its value is projected to escalate from $1.38 billion in 2025 to $1.48 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This past growth can be attributed to several factors including the increasing prevalence of coagulation disorders, the expansion of emergency care infrastructure, the availability of plasma-derived therapies, rising surgical procedure volumes, and the growing use of anticoagulant medications.

The prothrombin complex concentrate market is anticipated to experience substantial expansion over the coming years. By 2030, this market is projected to reach $1.96 billion, achieving a compound annual growth rate (CAGR) of 7.2%. Key factors contributing to this projected growth include the escalating demand for swift-acting coagulation treatments, increased capital expenditure in the development of recombinant factors, the proliferation of trauma care centers, a heightened emphasis on ensuring patient safety in anticoagulant regimens, and the wider implementation of standardized protocols for managing bleeding. Significant trends anticipated during this period encompass the growing preference for four-factor PCC products, the increasing application of PCC for rapid reversal of anticoagulation, the expanding need for emergency bleeding management solutions, the wider availability of recombinant coagulation products, and a stronger emphasis on hemostatic therapies that act quickly.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23488&type=smp

What Key Growth Drivers Are Influencing The Prothrombin Complex Concentrate Market?

The rising occurrence of bleeding disorders is projected to propel the expansion of the prothrombin complex concentrate market in the future. Bleeding disorders are medical conditions where the blood fails to clot adequately, leading to excessive bleeding due to the absence or improper function of clotting factors or platelets. The increase in these conditions is primarily attributed to the growing incidence of genetic conditions such as hemophilia, a rise in liver disease cases, the expanding use of anticoagulant medications, and a higher prevalence of vitamin K deficiencies. Prothrombin complex concentrate offers a treatment for bleeding disorders by rapidly replenishing clotting factors, which are crucial for effective blood coagulation and hemostasis. For instance, in October 2024, a report from the World Federation of Hemophilia, a Canada-based non-profit organization, indicated that in 2023, there were 179,703 recorded cases of hemophilia A. Among these, 162,040 cases (90%) were male, 6,990 cases were female, and 10,673 cases (6%) did not specify the patient’s sex. Consequently, the increasing prevalence of bleeding disorders is driving the growth of the prothrombin complex concentrate market. Prothrombin Complex Concentrate Market Driver: Growing Prescription Rate Of Anticoagulants Fueling The Market Due To Rising Prevalence Of Cardiovascular Diseases

The increasing prescription rate of anticoagulants is anticipated to boost the growth of the prothrombin complex concentrate market going forward. An anticoagulant is a substance that prevents or reduces the formation of blood clots by inhibiting coagulation factors or platelet aggregation. The rising prescription rate of anticoagulants is a result of the increasing prevalence of cardiovascular diseases, an aging global population, expanding clinical indications, enhanced screening programs, and advancements in anticoagulant therapy. Prothrombin complex concentrate works by counteracting the effects of anticoagulants, quickly replenishing clotting factors and restoring hemostasis in patients experiencing excessive bleeding or requiring urgent surgical procedures. For example, in June 2025, according to the Northern Ireland Statistics and Research Agency (NISRA), a UK-based government department, 64,000 individuals received oral anticoagulants in 2024/25, marking a 3.8% increase from the previous year, with 3.3% of the total population using these medications. Therefore, the growing prescription rate of anticoagulants is driving the growth of the prothrombin complex concentrate market.

How Is The Prothrombin Complex Concentrate Market Examined Through Segment Analysis?

The prothrombin complex concentrate market covered in this report is segmented –

1) By Product: 3-Factor Prothrombin Complex Concentrates, 4-Factor Prothrombin Complex Concentrates, Other Products

2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B), Trauma, Life-Threatening Coagulopathy With Acute Bleeding, Warfarin-Associated Acute, Life-Threatening Bleeding, Non-Warfarin Anticoagulant Reversal With Acute Bleeding

3) By Route Of Administration: Intravenous, Intravenous Infusion Variants, Intravenous Bolus Administration

4) By End-Use: Hospital And Ambulatory Surgical Centers, Specialty Clinics, Other End Users

Subsegments:

1) By 3-Factor PCC Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC), High-Dose 3-Factor Prothrombin Complex Concentrates (PCC), Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)

2) By 4-Factor PCC Typ: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC), High-Dose 4-Factor Prothrombin Complex Concentrates (PCC), Activated 4-Factor Prothrombin Complex Concentrates (PCC)

3) By Other Products: Recombinant Coagulation Factor Complexes, Plasma-Derived Coagulation Factor Complexes, Combination Therapy Products

Which Trends Are Contributing To Changes In The Prothrombin Complex Concentrate Market?

Major companies operating in the proteus syndrome market are focusing on conducting clinical trials to develop innovative products such as PI3K-α inhibitors, aiming to enhance treatment efficacy and expand therapeutic options. PI3K-α inhibitors are drugs that target the PI3K-alpha enzyme, which regulates cell growth and division. These inhibitors help manage proteus syndrome by reducing abnormal tissue overgrowth caused by mutations in the PIK3CA gene, which leads to excessive activation of the PI3K/AKT pathway. For instance, in November 2024, Risen (Suzhou) Pharma Technology Co., Ltd., a China-based pharmaceutical company, announced that its joint venture had received implicit approval for two clinical trials of its Class 1 new drug, RP903 tablets, under acceptance numbers CXHL2400566 and CXHL2400565. RP903 is a PI3K-α inhibitor designed to target PIK3CA gene mutations associated with proteus syndrome (PROS). This milestone highlights the company’s commitment to advancing innovative treatments for rare diseases and expanding therapeutic options for PROS patients.

Which Companies Are Influencing The Prothrombin Complex Concentrate Market?

Major companies operating in the prothrombin complex concentrate market are Pfizer Inc., Takeda Pharmaceutical Company Limited, CSL Behring GmbH, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd BPL, Prothya Biosolutions B.V., China Biologic Products Holdings Inc., Intas Pharmaceuticals Ltd, Biotest AG, Octapharma Plasma, Kamada Ltd, SK Plasma Co. Ltd, Reliance Life Sciences, Bharat Serums And Vaccines Limited

Access The Complete Prothrombin Complex Concentrate Market Report:

https://www.thebusinessresearchcompany.com/report/prothrombin-complex-concentrate-global-market-report

Which Region Is The Primary Market For The Prothrombin Complex Concentrate Market?

North America was the largest region in the prothrombin complex concentrate market in 2025. The regions covered in the prothrombin complex concentrate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Prothrombin Complex Concentrate Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=23488&type=smp

Browse Through More Reports Similar to the Global Prothrombin Complex Concentrate Market 2026, By The Business Research Company

Proteomics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Serine Proteases Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/serine-proteases-global-market-report

Pruritus Therapeutic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795